Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)Price and VolumeDetailed Quote
Top NewsMore NewsPerformanceMore NewsRead More
2 Healthcare Stocks for Beginner Investors With a 20-Year Time Horizon ↗
November 22, 2025
3 Mid-Cap Growth Stocks That Have Mammoth Long-Term Potential ↗
November 21, 2025
2 No-Brainer Healthcare Stocks to Buy Now ↗
November 18, 2025
2 Monster Stocks in the Making ↗
November 10, 2025
Is There a Future for Viking Therapeutics? ↗
November 09, 2025
Jim Cramer Says 'Take A Pass' On This Tech Stock, Won't Go Near Oils ↗
November 05, 2025
Here's Why Shares in Viking Therapeutics Shot Higher in October ↗
November 05, 2025
Prediction: The Next Eli Lilly Might Already Be Trading Under $50 ↗
November 03, 2025
Should You Buy Viking Therapeutics Before Nov. 5? ↗
November 02, 2025
10 Health Care Stocks Whale Activity In Today's Session ↗
October 30, 2025
Frequently Asked QuestionsIs Viking Therapeutics, Inc. - Common Stock publicly traded?
Yes, Viking Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Viking Therapeutics, Inc. - Common Stock trade on?
Viking Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Viking Therapeutics, Inc. - Common Stock?
The ticker symbol for Viking Therapeutics, Inc. - Common Stock is VKTX on the Nasdaq Stock Market
What is the current price of Viking Therapeutics, Inc. - Common Stock?
The current price of Viking Therapeutics, Inc. - Common Stock is 36.81
When was Viking Therapeutics, Inc. - Common Stock last traded?
The last trade of Viking Therapeutics, Inc. - Common Stock was at 11/28/25 01:00 PM ET
What is the market capitalization of Viking Therapeutics, Inc. - Common Stock?
The market capitalization of Viking Therapeutics, Inc. - Common Stock is 3.67B
How many shares of Viking Therapeutics, Inc. - Common Stock are outstanding?
Viking Therapeutics, Inc. - Common Stock has 4B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|